Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources
News and Community
About us

Otsuka Australia Pharmaceutical Pty Ltd

Regulatory activities for this sponsor.

Loading...

ARTG (14) ARTG (14)
Cancellation by sponsor (7) Cancellation by sponsor (7)
Australian Public Assessment Report (AusPAR) (2)
Designation or determination (1) Designation or determination (1)
Prescription medicine registration (1)

2025 (1) 2025 (1)
2021 (3) 2021 (3)
2020 (1) 2020 (1)
2019 (1) 2019 (1)
2018 (1) 2018 (1)
2017 (5) 2017 (5)
2016 (4) 2016 (4)
2012 (2) 2012 (2)
2008 (1) 2008 (1)
2003 (6) 2003 (6)

Search

Sponsor content

25 result(s) found, displaying 11 to 20

ABILIFY INJECTION aripiprazole 9.75 mg solution for injection vial Cancelled under Section 30(1)(c) of the Act

23 July 2019

Cancellation by sponsor

Requested by Otsuka Australia Pharmaceutical Pty Ltd
AusPAR: Tolvaptan

9 February 2018

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Tolvaptan
ABILIFY ODT aripiprazole 10mg orally disintegrating tablet blister pack Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Otsuka Australia Pharmaceutical Pty Ltd
ABILIFY ODT aripiprazole 15mg orally disintegrating tablet blister pack Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Otsuka Australia Pharmaceutical Pty Ltd
ABILIFY ODT aripiprazole 20mg orally disintegrating tablet blister pack Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Otsuka Australia Pharmaceutical Pty Ltd
ABILIFY ODT aripiprazole 30mg orally disintegrating tablet blister pack Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Otsuka Australia Pharmaceutical Pty Ltd
SAMSCA tolvaptan 15 mg tablet blister pack (176602)

5 April 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SAMSCA tolvaptan 15 mg tablet blister pack.
SAMSCA tolvaptan 30 mg tablet blister pack (176601)

5 April 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SAMSCA tolvaptan 30 mg tablet blister pack.
BUSULFEX busulfan 60mg/10mL injection vial (150612)

21 July 2008

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BUSULFEX busulfan 60mg/10mL injection vial.
ABILIFY aripiprazole 5mg tablet blister pack (90925)

21 May 2003

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ABILIFY aripiprazole 5mg tablet blister pack.

Pages

First page
Previous page
Page 1
Current page 2
Page 3
Next page
Last page

Is there anything wrong with this page?

Help us improve this page

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control - external site
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook - external site
(formerly Twitter) - external site
Youtube - external site
Instagram - external site
LinkedIn - external site

Help us improve

We are always looking for ways to improve our website.

Provide feedback - external site

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

Otsuka Australia Pharmaceutical Pty Ltd

Type

Date

Help us improve this page